NMAD
Lixte Biotechnology Holdings, Inc.
$6.93
+0.83 (+13.61%)
At close · Jul 8
Market Cap
$85.81M
Shares
12,382,944
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2018-12-31 | $24,702 | 10-K, filed 2020-03-25 |